How Did These 10 Predictions By Jim Cramer Turn Out?

7. Moderna, Inc. (NASDAQ:MRNA)

Number of Hedge Fund Holders: 44

A caller from New Jersey asked about Moderna, Inc. (NASDAQ:MRNA), explaining that some family members had owned it during its run-up to $400 and that he was now considering buying it around $130. Cramer confirmed his long-standing belief in the stock back then, saying:

“I’m a believer. I’ve been a believer with Steph Bancel since $16. I’ve never backed away, other than the fact it went crazy during COVID and then it crashed. And ever since it crashed, I’m in. I’m in.”

Cramer’s confidence in Moderna proved costly, as the stock plunged 81.28% over the past year.

Moderna, Inc. (NASDAQ:MRNA) is a biotechnology company specializing in mRNA-based vaccines and therapies, best known for its COVID-19 vaccine. Earlier in March, Cramer gave a reason for the stock’s recent dip, saying:

“Now, let’s consider the other side of the trade, the biggest losers, all of which were somehow connected to the data center except Moderna, which plunged 7% because of Financial Time’s story. It says they might… be targeted by RFK Junior at Health and Human Services and it’s certainly possible.”

Addressing the company’s struggles, Cramer said the following in April:

“[On MRNA being down after an FDA official resigning] I found that this was really extraordinary. Dedicated official. Obviously gonna be fired or has to leave. Has favored MRNA. MRNA had been part of the discourse to be able to . . .personalized cancer vaccines. If that’s halted. Then I think that you would question the worth of Moderna. David, Moderna… problematic. Problematic…”